Clinical Characteristic of Respiratory Tract Infections in Children during Pandemic Influenza (H1N1 2009) in Korea by 源�湲고솚 & 源��룞�닔
대유행 인플루엔자(H1N1 2009) 초기에 소아 호흡기 감염의 
임상특징 
김기환・박혜진・김동수
연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과
Original Article
Submitted: April 10 2010
Accepted:  April 22 2010
Corresponding author: Dong Soo Kim, M.D., Ph.D.
Address: Department of Pediatrics, Yonsei University 
College of Medicine, Shinchon-dong, Seodaemun-gu, Seoul 
120-752, Korea 
Tel: +82-2-2228-2057,  Fax: +82-2-393-9118
E-mail: dskim6634@yuhs.ac
Copyright © 2010 by The Korean Society of Infectious Diseases | Korean 
Society for Chemotherapy
DOI: 10.3947/ic.2010.42.2.76
Infect Chemother 2010;42(2):76-81
www.icjournal.org
Ki Hwan Kim, Hye Jin Park and Dong Soo Kim
Department of Pediatrics, Yonsei University College of 
Medicine, Severance Children’s Hospital, Seoul, Korea
Clinical Characteristic of Respiratory Tract Infections 
in Children during Pandemic Influenza (H1N1 2009) 
in Korea
Background: Since initial emergence on pandemic influenza (H1N1 2009) in 
Mexico on March 2009, the first case of pandemic influenza (H1N1 2009) occured 
on 2 May 2009 in Korea. We describe the clinical characteristics of childhood 
patients from pandemic influenza (H1N1 2009) and other concurrent respiratory 
pathogens during early phase of the pandemic influenza in Korea. 
Materials and Methods: We have retrospectively studied 959 patients under age of 
15 years who have visited Department of Emergency Medicine for a diagnostic test 
of pandemic influenza (H1N1 2009) or treatment of flu-like illness between May and 
September of 2009. The pandemic influenza (H1N1 2009) was detected via real-
time RT-PCR and other respiratory viruses were detected via multiplex RT-PCR. 
Results: A total of 959 patients visited Department of Emergency Medicine at 
Severance Hospital. Of them, 562 were tested; 124 (12.7%) were positive for 
pandemic influenza (H1N1 2009). Confirmed patients of pandemic influ enza 
(H1N1 2009) were relatively older than non-H1N1 patients (7.5 years of age vs 
4.6 years, P<0.001). Among histories or symptoms of patients with flu-like illness, 
contact history (80%) with another patient with pandemic influenza (H1N1 2009) 
was an important clue of the infection in early phase of pandemic. Comparing with 
hospitalized patients with respiratory tract infections due to other causes, lower 
ESR (32.9±23.5 mm/hour vs 11.5±9.2 mm/hour), hyperkalemia (4.2±0.3 mmol/
L vs 5.2±3 mmol/L) and hyponatremia (137.2±2.5 mmol/L vs 124±40.5 mmol/L) 
were significant laboratory finding and higher cholesterol and GTP were noticed in 
pandemic influenza (H1N1 2009). Ten confirmed patients with pandemic influenza 
(H1N1 2009) were hospitalized due to pneumonia and all of them were resolved 
without any complication.  
Conclusions: Respiratory tract infections were caused not only by pandemic 
influenza (H1N1 2009) virus but also various respiratory viruses. Hospitalized 
patients, confirmed as pandemic influenza (H1N1 2009), showed a good prognosis. 
Age and contact history were distinct features and could be an important clue to 
differentiate causes in patients with febrile respiratory symptoms.
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Introduction 
In March 2009, there was an outbreak of human respiratory 
disease in Mexico, cause of which was identified as a novel swine-
origin pandemic influenza (H1N1 2009) virus (S-OIV) (1). In 
California, S-OIV was also found in the school-aged children 
(2). In early June 2009, the World Health Organization (WHO) 
declared the outbreak of pandemic influenza (H1N1 2009) to be 
a pandemic. As of September 20, 2009, there were over 15,160 
confirmed cases of pandemic (H1N1) 2009 influenza; and 9 deaths 
had been reported in Korea. Of them 53% were aged between 
10 and 19 years old and 21% between 20 and 29 years old, which 
indicate the predominant occurrences of novel influenza viral 
infection in young adults (3). 
Reports in early phase of the Northern hemisphere said that 
most confirmed cases of pandemic influenza (H1N1 2009) have 
been self-limited and uncomplicated respiratory disease although 
some patients have been ill of hospitalized with more severe 
symptoms and some with increasing mortalities (1, 2, 4, 5). There 
was a report in Australia and New Zealand which had experienced 
pandemic influenza (H1N1 2009) in winter season saying that 
the critical illness had happened in infants and young adults (6). 
Children experienced more frequently the respiratory infections 
of various viruses or pathogens in winter season than in warmer 
seasons. The clinical symptoms of pandemic influenza (H1N1 
2009) had been similar to those infected with seasonal influenza 
and other viruses. 
In this report, we described the clinical characteristics of 
childhood patients showing febrile respiratory illness from 
pandemic influenza (H1N1 2009) or from other respiratory 
pathogens during early phase of the pandemic in Seoul, Korea.
Materials and Methods
We retrospectively studied patients under age of 15 years who 
visited Department of Emergency Medicine for a diagnostic test of 
pandemic influenza (H1N1 2009) or treatment of flu-like illness 
between May and September of 2009. The suspicious pandemic 
influenza (H1N1 2009) was defined as flu-like illness in this 
period with fever of over 37.8 degrees and respiratory symptoms 
including cough, rhinorrhea or nasal congestion. 
Laboratory diagnosis of pandemic influenza (H1N1 2009) 
was made by probe-based RT PCR (RocheⓇ, Germany) of 
nasopharyngeal swab (7). We also performed multiplex RT-PCR 
(SolgentⓇ, Korea) using the nasopharyngeal aspiration samples. 
This test was done to identify other respiratory viral pathogens 
in hospitalized patients who had not been tested or have been 
ruled out for pandemic influenza (H1N1 2009) for their respiratory 
infection such as pneumonia, bronchiolitis, croup, asthma and 
acute respiratory distress syndrome during the same period (8). 
The target viruses were adenovirus, parainfluenza virus type 
1, type 2 and type 3, respiratory syncytial virus, influenza A and 
B virus, coronavirus, rhinovirus, and bocavirus. Those patients 
diagnosed as influenza A virus were reconfirmed as seasonal 
influenza A virus by sequencing.
We analyzed clinical characteristics of patients population who 
was done a diagnostic test a diagnostic test and compared features 
of these patients. Also, we showed various respiratory viral 
pathogens detected during the same period. We also described 
progress and treatments for inpatients with pandemic influenza 
(H1N1 2009).
Characteristics of patients are analyzed by frequency, and chi-
square test. 
Results
1. Characteristics of study population
Between May and September 2009, 959 patients under age of 15 
years visited hospital for a diagnostic test of pandemic influenza 
(H1N1 2009) or treatment of flu-like illness (Fig. 1). Of them, 519 
Figure 1. The number of patients with flu-like illness increases in warm and hot 
seasons and that of confirmed pandemic influenza (H1N1 2009) cases increases 
simultaneously. H1N1, pandemic influenza (H1N1 2009)
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were males (54%) and 440 were females (46%). Average age was 
5.2 years. Out of total 959, 562 patients were tested for pandemic 
influenza (H1N1 2009) and 124 (22%) were confirmed with 
pandemic influenza (H1N1 2009). This result accounts for 12.7% 
of total 959 patients. There were no distinctive  gender difference 
between pandemic influenza (H1N1 2009) patients and non-
H1N1 patients. Average age for pandemic influenza (H1N1 2009) 
confirmed patients was 7.5 years old while non-H1N1 patients with 
4.6 years old (P<0.001). The contact history with other pandemic 
influenza (H1N1 2009) patient was found more frequent in the 
pandemic influenza (H1N1 2009) confirmed cases than non-
H1N1 cases (P=0.03).  No other symptoms or travel history were 
different between them.
2. Symptoms
Most common symptoms of confirmed pandemic influenza 
(H1N1 2009) patients were fever, cough, rhinorrhea, sore throat, 
sputum; some had headache, myalgia, vomiting, abdominal pain, 
nausea and diarrhea (Table 1). Similar symptoms were found in 
non-H1N1 patients. Based on symptoms, it could not be possible 
to differentiate patients of pandemic influenza (H1N1 2009) from 
those with other reasons. Only the number of cases with cough 
was higher in patients with pandemic influenza (H1N1 2009) 
than other patients (P<0.001). Of total 959 patients, 27 needed 
hospitalization. Main reasons for hospitalization were pneumonia 
and dehydration caused by fever.
3. Patients needed to be hospitalized
A total of 27 patients needed to be hospitalized. Of them, 10 
patients were confirmed as pandemic influenza (H1N1 2009). 
These 10 patients accounted for 8.1% of total 124 confirmed 
pandemic influenza (H1N1 2009) patients. Severe productive 
cough with fever and interstitial opacities on their chest radiographs 
were manifested, which were consistent with pneumonia. On the 
contrary, 14 out of 17 non-H1N1 patients were hospitalized due 
to pneumonia, one of which had a croup. Two of 17 non-H1N1 
patients were hospitalized due to dehydration from high fever, 
one of which was confirmed as urinary tract infection.  Remaining 
1 patient of 17 non-H1N1 patients was hospitalized given febrile 
convulsion with high fever. Average age hospitalized patients was 
5.5 years in confirmed pandemic influenza (H1N1 2009) patients 
and 2.6 years in non-H1N1 patients (P=0.008). 
Of those patients with confirmed pandemic influenza (H1N1 
2009), 2 with pneumonia showed anti-Mycoplasma IgG above 
a titer of 1:320 and were regarded as Mycoplasma co-infection. 
Other bacterial pathogens had not been identified. Two cases of 
pneumonia were caused by adenovirus in non-H1N1 patients. No 
other reasons for pneumonia were found in the remaining cases. 
We also noted that leukocyte value was relatively lower in 
patients with pandemic influenza (H1N1 2009) than in non-
H1N1 pneumonia patients (6,690/mm3 vs 12,097/mm3, P=0.080). 
C-reactive protein increased in patients with pandemic influenza 
(H1N1 2009) as non-H1N1 patients showed (21 vs 44.9, P=0.065). 
Erythrocyte sedimentation rate did not increase in pandemic 
influenza (H1N1 2009) patients (11.5 mm/hour vs 32.9 mm/hour, 
P=0.033). ALT levels in pandemic influenza (H1N1 2009) patients 
were in the normal range. Patients with pandemic influenza (H1N1 
2009) showed distinct electrolyte imbalance of hyponatremia 
and hyperkalemia (124 mEq/dL, 5.2 mEq/dL respectively, P=0.015, 
P=0.021) (Table 2). 
Symptoms of 8 patients with confirmed pandemic influenza 
(H1N1 2009) improved just with oseltamivir at the dose 
recommended by WHO together with ampicillin-sulbactam or 
amoxicillin-clavulanate. Within 2 days of hospitalization, other 
two patients showed dyspnea accompanying wheezing and 
rapid progressive pneumonia even though they were taking the 
oseltamivir. One of them showed bilateral patchy alveolar opacities 
during hospitalization. They needed additional antibiotics of 
glycopeptides and corticosteroid together with intravenous 
immunoglobulin. Clinical improvement was achieved after the 
additional treatments in 5 days without management at intensive 
care unit. These patients recovered without other complications. 
Average hospitalization was 4.2 days (3 to 7 days). There were no 
Table 1. Clinical Features of Patients with Flu-like Illness
H1N1 Other viruses P value
Sex (%, male) 54 54 0.518
Contact history (%) 80 42 0.000
Travel history (%)   6 20 0.018
Fever (%) 95 94 0.361
Cough (%) 85 71 0.001
Sputum (%) 48 46 0.43
Rhinorrhea (%) 71 71 0.533
Sore throat (%) 73 77 0.358
Nasal obstruction (%) 50 74 0.048
Myalgia (%) 61 43 0.183
Lethargy (%) 24 33 0.305
Headache (%) 43 58 0.169
Nausea (%) 11   6 0.221
Vomiting (%) 18 17 0.46
Diarrhea (%) 10 15 0.269
Abdominal pain (%) 25 50 0.044
H1N1, pandemic influenza (H1N1 2009) virus
The proportions of each symptom were derived from different numbers of patients 
recognized according to each symptom.
  DOI: 10.3947/ic.2010.42.2.76  •  Infect Chemother 2010;42(2):76-81      79www.icjournal.org
patients with neurological or cardiac complications.
4. Other respiratory viruses
During the same period, We investigated 216 additional 
hospitalized patients with acute respiratory infectious disease 
for causative viruses by multiplex RT-PCR such as pneumonia, 
bronchiolitis, croup or acute respiratory distress syndrome. They 
showed negative result with H1N1 2009 RT-PCR. Causative 
viruses were found in 151 (69.9%) out of 216 patients. Among them, 
there were 121 cases with rhinovirus (56%), 31 with adenovirus, 
17 with bocavirus, 2 with seasonal influenza, 3 with respiratory 
syncytial virus, 2 with parainfluenza virus and 1 with coronavirus 
(Fig. 2).  
Discussion
The first case with pandemic influenza (H1N1 2009) in Korea 
was an adult who traveled in an epidemic country and came 
back with febrile symptoms (3). We believe that there has been 
continuous inflow from overseas since then and spread rapidly. In 
this study, we showed that children with flu-like illness in the early 
phase of pandemic influenza (H1N1 2009) pandemic had been 
affected not only by pandemic influenza virus, but also by various 
seasonal viruses. 
While influenza virus used to be the major virus causing 
respiratory diseases in winter, pandemic influenza (H1N1 2009) 
became a major concern because the virus was new type. When 
we treated patients, pandemic influenza (H1N1 2009) was 
becoming important issue in judging clinical treatment. Pandemic 
influenza (H1N1 2009) which had started to prevail during 
summer in Korea was a new menace and its speed of spread had 
been known as faster than any other influenza viruses. In addition, 
although the case fatality of pandemic influenza (H1N1 2009) was 
known to be similar to that of seasonal influenza, there had been 
many reports on deaths related to pandemic influenza (H1N1 
2009). Accordingly, in clinical setting, it was important to diagnose 
whether pandemic influenza (H1N1 2009) infection has occurred 
or not, and to start empirical treatment for children.
In this report, we performed a diagnostic test for pandemic 
influenza (H1N1 2009) which accounts for 60.4% of total patients 
with flu-like illness. Of these, we diagnosed 22% confirmed 
cases which account for 12.9% of total visited patients. Clinically, 
there were several distinctive characters in pandemic influenza 
(H1N1 2009) infected patients. The most distinctive one between 
H1N1 patients and non-H1N1 patients was age. Age of H1N1 
patients average 7.2 years old. Those hospitalized patients due to 
confirmed H1N1 were aged over 5 years old. It has been known 
that patients with lower respiratory tract infection due to other 
respiratory viruses including seasonal influenza are mostly found 
for children below 3 years old; and RSV are most commonly 
found in children under 12 months old (9, 10). Considering fast 
transmission speed of pandemic influenza (H1N1 2009) (11),  it 
Figure 2. Various respiratory pathogenic viruses circulated during early phase of 
pandemic. Rhinovirus and adenovirus caused the respiratory infection in children 
at the same time with pandemic influenza (H1N1 2009) virus. 
ADV, adenovirus; PIV, parainfluenza virus; hRV, human rhinovirus; hBoV, human 
bovca virus; H1N1, pandemic influenza (H1N1 2009)
Table 2. Laboratory Features of Hospitalized Patients
H1N1 Other viruses P value
Age (years) 5.5±4.4 2.6±1.8 0.017
White blood cell (/μL) 6690±2755.8 12097.1±7203.9 0.08
Hemoglobin (g/dL) 12.2±0.7 11.5±0.9 0.445
Platelet (/μL) 245777.8±82203.7 274571.4±88277.3 0.576
ESR (mm/hour) 11.5±9.2 32.9±23.5 0.033
CRP (mg/L) 21±22.5 44.9±45 0.065
Ca (mg/dL) 9.3±0.6 9.2±0.4 0.126
Phosphorus (mg/dL) 4.7±0.5 4.2±0.8 0.069
Glucose (mg/dL) 105.3±10.1 96±13.8 0.339
BUN (mg/dL) 8.6±2.2 10.8±5.6 0.177
Creatinine (mg/dL) 0.5±0.1 0.4±0.1 0.276
Uric acid (mg/dL) 4±1.1 4.3±1.4 0.534
Cholesterol (mg/dL) 143.2±10 134.2±26.3 0.001
Protein (g/dL) 6.6±0.5 6.7±0.7 0.207
Albumin (g/dL) 4.5±0.3 4.3±0.3 0.438
AST (IU/L) 62.3±61.6 37.4±15.3 0.001
ALT (IU/L) 34.9±47.6 16.1±7.5 0.006
Na (mmol/L) 124±40.5 137.2±2.5 0.015
K (mmol/L) 5.2±3 4.2±0.3 0.021
Cl (mmol/L) 103.6±1.9 103.3±2 0.826
H1N1, pandemic influenza (H1N1 2009)
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could explain that children in kindergartens or school would show 
high incidence. Secondarily, most patients had contact history with 
other patients with H1N1 infection. The patient’s history would be 
important clue for exploring cause of their symptoms.
Also, we need to consider other viruses in managing the 
patients. Of total flu-like illness, 13% were confirmed pandemic 
influenza (H1N1 2009). Other viruses including adenovirus, 
human bocavirus and human rhinovirus were identified in about 
70% of the hospitalized patients with respiratory infection. It is 
difficult to differentiate the causative agents just with symptoms 
and physical examination of patients. This difficulty of making 
clinical diagnosis leads inappropriate use of antibiotics or antiviral 
agents like oseltamivir. Despite the mild presentations of pandemic 
influenza, the public response to novel viral disease had to make 
care burden in Korea, particularly in tertiary hospital. Reports of 
deaths from the pandemic influenza contributed to excessive visit 
to tertiary hospital where the Korean Center of Disease Control 
and Prevention assigned for control of pandemic influenza. In a 
condition of similar level of virulence with seasonal flu and high 
transmissibility, the antiviral therapy and chemophylaxis were 
recommended to limited persons who are hospitalized with 
severe flu-like illness, contact with a known patient and high risk 
of complications from influenza (12). Our experience suggests 
that the conservative management of mild flu presentation is 
recommendable as a measure against re-attack of virus next 
season.     
Thirdly, laboratory characteristics in influenza A (H1N1) 
infection, revealed less dominant leukocytosis, less inflammatory 
signs, and rapid progressive electrolytes imbalance. In cases of 
seasonal influenza, Fas–Fas ligand signaling induces apoptosis, 
and plays a major role in regulating leukocyte population (13). 
In children with pandemic influenza (H1N1 2009), electrolytes 
imbalance, particularly hypokalemia (15, 16) or hyperkalemia 
(17) was reported of which mechanism are unknown. In our 
patients with hyperkalemia or hyponatremia, they recovered soon 
after sufficient hydration. The levels of cholesterol and ALT were 
significantly higher than those in non-H1N1 patients, but in normal 
ranges; and the cause of their change is to be studied.
In the treatment for pandemic influenza (H1N1 2009) 
conservative treatment and antiviral agent like oseltamivir were 
important. But in severe cases of complicated rapid progressive 
pneumonia, we tried antibiotics and corticosteroid. The use of 
antibiotics is well accepted treatment for secondary bacterial 
pneumonia following the influenza. Even if corticosteroid use for 
influenza is well supported. The use of corticosteroid seem likely 
to reduce the inflammatory response in acute phase of influenza 
or other respiratory virus infection (18). Because the excessive 
inflammation is known to be the major cause of mortality in 
influenza pneumonia (19), corticosteroid is thought to be the 
treatment of choice for some patients with complicated severe 
pneumonia or respiratory difficulty. 
Our study has some limitations. This is a small case series from 
a tertiary medical center in Seoul, Korea and our findings may not 
be generalized to other pediatric populations. The number of 
subjects with pandemic influenza (H1N1 2009) may have been 
underestimated as some visited patients were excluded from 
pandemic influenza (H1N1 2009) test because of its expensive 
costs. Some parents of patients asked for antiviral agent therapy 
without test.  
To our knowledge, this is the first report to show concurrent 
viral diseases with pandemic influenza (H1N1 2009) in pandemic 
period and to describe the clinical features in children in Korea. 
Conclusively, during early phase of pandemic influenza (H1N1 
2009) pandemic various respiratory viruses were also important 
causes for flu-like illness, while some patients were confirmed 
as pandemic influenza (H1N1 2009) and hospitalized. Age 
population and contact history were distinct features and could 
be an important clue to discriminate causes in patients with febrile 
respiratory symptoms.
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